Metabolic indices of polyunsaturated fatty acids: current evidence, research controversies, and clinical utility

References

• Aarsetoey, H., R. Aarsetoey, T. Lindner, H. Staines, W. S. Harris, and D. W. T. Nilsen. 2011. Low levels of the omega-3 index are associated with sudden cardiac arrest and remain stable in survivors in the subacute phase. Lipids 46 (2):151–61. doi:10.1007/s11745-010-3511-3.
   PubMed Web of Science ®Google Scholar
• Abel, S., S. Riedel, and W. C. Gelderblom. 2014. Dietary PUFA and cancer. The Proceedings of the Nutrition Society 73:361–7.
   PubMed Web of Science ®Google Scholar
• Angulo, P. 2007. Obesity and nonalcoholic fatty liver disease. Nutrition Review 65 (6):57–63. doi:10.1111/j.1753-4887.2007.tb00329.x.
   Web of Science ®Google Scholar
• Araya, J., R. Rodrigo, L. A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, and J. Poniachik. 2004. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clinical Science 106 (6):635–43. doi:10.1042/CS20030326.
   PubMed Web of Science ®Google Scholar
• Argo, C. K., J. T. Patrie, C. Lackner, T. D. Henry, E. E. de Lange, A. L. Weltman, N. L. Shah, A. M. Al-Osaimi, P. Pramoonjago, S. Jayakumar, et al. 2015. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial. Journal of Hepatology 62 (1):190–7. doi:10.1016/j.jhep.2014.08.036.
   PubMed Web of Science ®Google Scholar
• Arita, M., C. B. Clish, and C. N. Serhan. 2005. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-inflammatory resolvins: Novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochemical and Biophysical Research Communications 338 (1):149–57. doi:10.1016/j.bbrc.2005.07.181.
   PubMed Web of Science ®Google Scholar
• Baack, M. L., S. E. Puumala, S. E. Messier, D. K. Pritchett, and W. S. Harris. 2016. Daily enteral DHA supplementation alleviates deficiency in premature infants. Lipids 51 (4):423–33. doi:10.1007/s11745-016-4130-4.
   PubMed Web of Science ®Google Scholar
• Baghai, T. C., G. Varallo-Bedarida, C. Born, S. Häfner, C. Schüle, D. Eser, R. Rupprecht, B. Bondy, and C. von Schacky. 2011. Major depressive disorder is associated with cardiovascular risk factors and low omega-3 Index. The Journal of Clinical Psychiatry 72 (09):1242–7. doi:10.4088/JCP.09m05895blu.
   PubMedGoogle Scholar
• Bailey-Hall, E., E. B. Nelson, and A. S. Ryan. 2008. Validation of a rapid measure of blood PUFA levels in humans. Lipids 43 (2):181–6. doi:10.1007/s11745-007-3140-7.
   PubMed Web of Science ®Google Scholar
• Bell, J. G., E. E. Mackinlay, J. R. Dick, I. Younger, B. Lands, and T. Gilhooly. 2011. Using a fingertip whole blood sample for rapid fatty acid measurement: Method validation and correlation with erythrocyte polar lipid compositions in UK subjects. British Journal of Nutrition 106:1408–15. doi:10.1017/S0007114511001978.
   PubMed Web of Science ®Google Scholar
• Berger, M. E., S. Smesny, S.-W. Kim, C. G. Davey, S. Rice, Z. Sarnyai, M. Schlögelhofer, M. R. Schäfer, M. Berk, P. D. McGorry, et al. 2017. Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: A 7-year longitudinal study. Translational Psychiatry 7 (8):e1220–e1220. doi:10.1038/tp.2017.190.
   PubMedGoogle Scholar
• Berquin, I. M., I. J. Edwards, and Y. Q. Chen. 2008. Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Letters 269 (2):363–77. doi:10.1016/j.canlet.2008.03.044.
   PubMed Web of Science ®Google Scholar
• Brenna, J. T. 2013. Fatty acid analysis by high resolution gas chromatography and mass spectrometry for clinical and experimental applications. Current Opinion in Clinical Nutrition and Metabolic Care 16 (5):548–54. doi:10.1097/MCO.0b013e328363bc0a.
   PubMed Web of Science ®Google Scholar
• Brenna, J. T., M. Plourde, K. D. Stark, P. J. Jones, and Y.-H. Lin. 2018. Best practices for the design, laboratory analysis, and reporting of trials involving fatty acids. The American Journal of Clinical Nutrition 108 (2):211–27. doi:10.1093/ajcn/nqy089.
   PubMed Web of Science ®Google Scholar
• Burla, B., M. Arita, M. Arita, A. K. Bendt, A. Cazenave-Gassiot, E. A. Dennis, K. Ekroos, X. Han, K. Ikeda, G. Liebisch, et al. 2018. MS-based lipidomics of human blood plasma: A community-initiated position paper to develop accepted guidelines. Journal of Lipid Research 59 (10):2001–17. doi:10.1194/jlr.S087163.
   PubMed Web of Science ®Google Scholar
• Calder, P. C. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. The American Journal of Clinical Nutrition 83 (6):1505S–19S. doi:10.1093/ajcn/83.6.1505S.
   PubMed Web of Science ®Google Scholar
• Caspar-Bauguil, S., A. Fioroni, A. Galinier, S. Allenbach, M. C. Pujol, R. Salvayre, A. Cartier, I. Lemieux, D. Richard, S. Biron, et al. 2012. Pro-inflammatory phospholipid arachidonic acid/eicosapentaenoic acid ratio of dysmetabolic severely obese women. Obesity Surgery 22 (6):935–44. doi:10.1007/s11695-012-0633-0.
   PubMed Web of Science ®Google Scholar
• Catalá, A. 2013. Five decades with polyunsaturated Fatty acids: Chemical synthesis, enzymatic formation, lipid peroxidation and its biological effects. Journal of Lipids 2013:710290. doi:10.1155/2013/710290.
   PubMedGoogle Scholar
• Chalasani, N., Z. Younossi, J. E. Lavine, A. M. Diehl, E. M. Brunt, K. Cusi, M. Charlton, A. J. Sanyal, and American Association for the Study of Liver Diseases; American College of Gastroenterology; American Gastroenterological Association 2012. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Gastroenterology 107 (6):811–26. doi:10.1053/j.gastro.2012.04.001.
   Web of Science ®Google Scholar
• Chiappini, F., A. Coilly, H. Kadar, P. Gual, A. Tran, C. Desterke, D. Samuel, J.-C. Duclos-Vallée, D. Touboul, J. Bertrand-Michel, et al. 2017. Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients. Scientific Reports 7 (1):46658. doi:10.1038/srep46658.
   PubMedGoogle Scholar
• Colussi, G., C. Catena, M. Novello, N. Bertin, and L. A. Sechi. 2017. Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes. Nutrition, Metabolism, and Cardiovascular Diseases: NMCD 27 (3):191–200. doi:10.1016/j.numecd.2016.07.011.
   PubMed Web of Science ®Google Scholar
• Cottin, S. C., T. A. Sanders, and W. L. Hall. 2011. The differential effects of EPA and DHA on cardiovascular risk factors. Proceedings of the Nutrition Society 70 (2):215–31. doi:10.1017/S0029665111000061.
   PubMed Web of Science ®Google Scholar
• Cruciani, G., P. Domingues, M. Fedorova, F. Galli, and C. M. Spickett. 2019. Redox lipidomics and adductomics - Advanced analytical strategies to study oxidized lipids and lipid-protein adducts. Free Radical Biology and Medicine 144:1–5. doi:10.1016/j.freeradbiomed.2019.07.027.
   PubMed Web of Science ®Google Scholar
• Dasilva, G., and I. Medina. 2019. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators. Free Radical Biology and Medicine 144:90–109. doi:10.1016/j.freeradbiomed.2019.03.017.
   PubMed Web of Science ®Google Scholar
• Davidson, M. H. 2013. Omega-3 fatty acids: New insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid. Current Opinion in Lipidology 24 (6):467–74. doi:10.1097/MOL.0000000000000019.
   PubMed Web of Science ®Google Scholar
• Davinelli, S., G. Corbi, S. Righetti, E. Casiraghi, F. Chiappero, S. Martegani, R. Pina, I. De Vivo, A. P. Simopoulos, and G. Scapagnini. 2019. Relationship between distance run per week, omega-3 index, and arachidonic acid (AA)/eicosapentaenoic acid (EPA) ratio: An observational retrospective study in non-elite runners. Frontiers in Physiology 10:487. doi:10.3389/fphys.2019.00487.
   PubMed Web of Science ®Google Scholar
• Davinelli, S., G. Corbi, S. Righetti, B. Sears, H. H. Olarte, D. Grassi, and G. Scapagnini. 2018a. Cardioprotection by Cocoa Polyphenols and ω-3 Fatty Acids: A Disease-Prevention Perspective on Aging-Associated Cardiovascular Risk. Journal of Medicinal Food 21 (10):1060–9. doi:10.1089/jmf.2018.0002.
   PubMed Web of Science ®Google Scholar
• Davinelli, S., G. Corbi, A. Zarrelli, M. Arisi, P. Calzavara-Pinton, D. Grassi, I. De Vivo, and G. Scapagnini. 2018b. Short-term supplementation with flavanol-rich cocoa improves lipid profile, antioxidant status and positively influences the AA/EPA ratio in healthy subjects. The Journal of Nutritional Biochemistry 61:33–9. doi:10.1016/j.jnutbio.2018.07.011.
   PubMed Web of Science ®Google Scholar
• Deacon, G., C. Kettle, D. Hayes, C. Dennis, and J. Tucci. 2017. Omega 3 polyunsaturated fatty acids and the treatment of depression. Critical Reviews in Food Science and Nutrition 57 (1):212–23. doi:10.1080/10408398.2013.876959.
   PubMed Web of Science ®Google Scholar
• D’Eliseo, D., and F. Velotti. 2016. Omega-3 fatty acids and cancer cell cytotoxicity: Implications for multi-targeted cancer therapy. Journal of Clinical Medicine 5:E15. doi:10.3390/jcm5020015.
   PubMed Web of Science ®Google Scholar
• de Lorgeril, M., S. Renaud, N. Mamelle, P. Salen, J. L. Martin, I. Monjaud, J. Guidollet, P. Touboul, and J. Delaye. 1994. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. The Lancet 343 (8911):1454–9. doi:10.1016/S0140-6736(94)92580-1.
   PubMed Web of Science ®Google Scholar
• Del Gobbo, L. C., F. Imamura, S. Aslibekyan, M. Marklund, J. K. Virtanen, M. Wennberg, M. Y. Yakoob, S. E. Chiuve, L. Dela Cruz, A. C. Frazier-Wood, et al. 2016. ω-3 polyunsaturated fatty acid biomarkers and coronary heart disease: Pooling project of 19 cohort studies. JAMA Internal Medicine 176 (8):1155–66. doi:10.1001/jamainternmed.2016.2925.
   PubMed Web of Science ®Google Scholar
• Delarue, J., and J. P. Lallès. 2016. Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA. Molecular Nutrition & Food Research 60:147–59. doi:10.1002/mnfr.201500346.
   PubMed Web of Science ®Google Scholar
• Domei, T., H. Yokoi, S. Kuramitsu, Y. Soga, T. Arita, K. Ando, S. Shirai, K. Kondo, K. Sakai, M. Goya, et al. 2012. Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention. Circulation Journal 76 (2):423–9. doi:10.1253/circj.CJ-11-0941.
   PubMed Web of Science ®Google Scholar
• Dupuy, A., P. Le Faouder, C. Vigor, C. Oger, J. M. Galano, C. Dray, J. C. Lee, P. Valet, C. Gladine, T. Durand, et al. 2016. Simultaneous quantitative profiling of 20 isoprostanoids from omega-3 and omega-6 polyunsaturated fatty acids by LC-MS/MS in various biological samples. Analytica Chimica Acta 921:46–58. doi:10.1016/j.aca.2016.03.024.
   PubMed Web of Science ®Google Scholar
• Dyerberg, J., and H. O. Bang. 1979. Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. The Lancet. 2:433–5. doi:10.1016/S0140-6736(79)91490-9.
   PubMed Web of Science ®Google Scholar
• EFSA Panel on Dietetic Products. 2010. Scientific opinion on dietary reference values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal 8:1461–568.
   Google Scholar
• EFSA. 2009. Scientific opinion—Labelling reference intake values forn-3 and n-6 polyunsaturated fatty acids. EFSA Journal 1176:1–11.
   Google Scholar
• Fedor, D., and D. S. Kelley. 2009. Prevention of insulin resistance by n-3 polyunsaturated fatty acids. Current Opinion in Clinical Nutrition and Metabolic Care 12 (2):138–46. doi:10.1097/MCO.0b013e3283218299.
   PubMed Web of Science ®Google Scholar
• Fokkema, M. R., E. N. Smit, I. A. Martini, H. A. Woltil, E. R. Boersma, and F. a. J. Muskiet. 2002. Assessment of essential fatty acid and omega3-fatty acid status by measurement of erythrocyte 20:3omega9 (Mead acid), 22:5omega6/20:4omega6 and 22:5omega6/22:6omega3. Prostaglandins, Leukotrienes, and Essential Fatty Acids 67 (5):345–56. doi:10.1054/plef.2002.0440.
   PubMed Web of Science ®Google Scholar
• Fontes, J. D., F. Rahman, S. Lacey, M. G. Larson, R. S. Vasan, E. J. Benjamin, W. S. Harris, and S. J. Robins. 2015. Red blood cell fatty acids and biomarkers of inflammation: A cross-sectional study in a community-based cohort. Atherosclerosis 240 (2):431–6. doi:10.1016/j.atherosclerosis.2015.03.043.
   PubMed Web of Science ®Google Scholar
• Fujihara, M., M. Fukata, K. Odashiro, T. Maruyama, K. Akashi, and Y. Yokoi. 2013. Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease. Angiology 64 (2):112–8. doi:10.1177/0003319712437031.
   PubMed Web of Science ®Google Scholar
• Gebauer, S. K., T. L. Psota, W. S. Harris, and P. M. Kris-Etherton. 2006. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. The American Journal of Clinical Nutrition 83 (6):1526S–35S. doi:10.1093/ajcn/83.6.1526S.
   PubMed Web of Science ®Google Scholar
• Giusepponi, D., R. Galarini, C. Barola, P. Torquato, D. Bartolini, S. Moretti, G. Saluti, A. Gioiello, C. Libetta, and F. Galli. 2019. LC-MS/MS assay for the simultaneous determination of tocopherols, polyunsaturated fatty acids and their metabolites in human plasma and serum. Free Radical Biology and Medicine 144:134–43. doi:10.1016/j.freeradbiomed.2019.04.017.
   PubMed Web of Science ®Google Scholar
• Goodstine, S. L., T. Zheng, T. R. Holford, B. A. Ward, D. Carter, P. H. Owens, and S. T. Mayne. 2003. Dietary (n-3)/(n-6) fatty acid ratio: Possible relationship to premenopausal but not postmenopausal breast cancer risk in U.S. women. The Journal of Nutrition 133 (5):1409–14. doi:10.1093/jn/133.5.1409.
   PubMed Web of Science ®Google Scholar
• Guebre-Egziabher, F., R. Rabasa-Lhoret, F. Bonnet, J.-P. Bastard, M. Desage, M. R. Skilton, H. Vidal, and M. Laville. 2008. Nutritional intervention to reduce the n-6/n-3 fatty acid ratio increases adiponectin concentration and fatty acid oxidation in healthy subjects. European Journal of Clinical Nutrition 62 (11):1287–93. doi:10.1038/sj.ejcn.1602857.
   PubMed Web of Science ®Google Scholar
• Harizi, H., J.-B. Corcuff, and N. Gualde. 2008. Arachidonic-acid-derived eicosanoids: Roles in biology and immunopathology. Trends in Molecular Medicine 14 (10):461–9. doi:10.1016/j.molmed.2008.08.005.
   PubMed Web of Science ®Google Scholar
• Harnack, K., G. Andersen, and V. Somoza. 2009. Quantitation of alpha-linolenic acid elongation to eicosapentaenoic and docosahexaenoic acid as affected by the ratio of n6/n3 fatty acids. Nutrition & Metabolism 6:8. doi:10.1186/1743-7075-6-8.
   PubMed Web of Science ®Google Scholar
• Harris, W. S. 2006. The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses. Current Atherosclerosis Reports 8 (6):453–9. doi:10.1007/s11883-006-0019-7.
   PubMedGoogle Scholar
• Harritus, W. S. 2007. Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor. Pharmacological Research 55 (3):217–23. doi:10.1016/j.phrs.2007.01.013.
   PubMed Web of Science ®Google Scholar
• Harris, W. S. 2008. The omega-3 index as a risk factor for coronary heart disease. The American Journal of Clinical Nutrition 87 (6):1997S–2002S. doi:10.1093/ajcn/87.6.1997S.
   PubMed Web of Science ®Google Scholar
• Harris, W. S. 2018. The omega-6:omega-3 ratio: A critical appraisal and possible successor. Prostaglandins, Leukotrienes, and Essential Fatty Acids 132:34–40. doi:10.1016/j.plefa.2018.03.003.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., B. Assaad, and W. C. Poston. 2006. Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease. The American Journal of Cardiology 98 (4):19–26. doi:10.1016/j.amjcard.2005.12.023.
   PubMedGoogle Scholar
• Harris, W. S., L. Del Gobbo, and N. L. Tintle. 2017. The omega-3 index and relative risk for coronary heart disease mortality: Estimation from 10 cohort studies. Atherosclerosis 262:51–4. doi:10.1016/j.atherosclerosis.2017.05.007.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., D. Mozaffarian, E. Rimm, P. Kris-Etherton, L. L. Rudel, L. J. Appel, M. M. Engler, M. B. Engler, and F. Sacks. 2009. Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 119:902–7. doi:10.1161/CIRCULATIONAHA.108.191627.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., W. C. Poston, and C. K. Haddock. 2007. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 193 (1):1–10. doi:10.1016/j.atherosclerosis.2007.03.018.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., J. V. Pottala, S. A. Varvel, J. J. Borowski, J. N. Ward, and J. P. McConnell. 2013a. Erythrocyte omega-3 fatty acids increase and linoleic acid decreases with age: Observations from 160,000 patients. Prostaglandins, Leukotrienes, and Essential Fatty Acids 88 (4):257–63. doi:10.1016/j.plefa.2012.12.004.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., S. A. Varvel, J. V. Pottala, G. R. Warnick, and J. P. McConnell. 2013b. Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility. Journal of Clinical Lipidology 7 (5):433–40. doi:10.1016/j.jacl.2013.05.001.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., S. A. Sands, S. L. Windsor, H. A. Ali, T. L. Stevens, A. Magalski, C. B. Porter, and A. M. Borkon. 2004. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: Correlation with erythrocytes and response to supplementation. Circulation 110 (12):1645–9. doi:10.1161/01.CIR.0000142292.10048.B2.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., and R. M. Thomas. 2010. Biological variability of blood omega-3 biomarkers. Clinical Biochemistry 43 (3):338–40. doi:10.1016/j.clinbiochem.2009.08.016.
   PubMed Web of Science ®Google Scholar
• Harris, W. S., and C. Von Schacky. 2004. The omega-3 index: A new risk factor for death from coronary heart disease? Preventive Medicine 39 (1):212–20. doi:10.1016/j.ypmed.2004.02.030.
   PubMed Web of Science ®Google Scholar
• Hashimoto, T., J. Ako, K. Nakao, Y. Ozaki, K. Kimura, T. Noguchi, S. Yasuda, S. Suwa, K. Fujimoto, Y. Nakama, et al. 2018. A lower eicosapentaenoic acid/arachidonic acid ratio is associated with in-hospital fatal arrhythmic events in patients with acute myocardial infarction: A J-MINUET substudy. Heart and Vessels 33 (5):481–8. doi:10.1007/s00380-017-1084-2.
   PubMed Web of Science ®Google Scholar
• He, X. X., X. L. Wu, R. P. Chen, C. Chen, X. G. Liu, B. J. Wu, and Z. M. Huang. 2016. Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials. PLoS One 11 (10):e0162368. doi:10.1371/journal.pone.0162368.
   PubMed Web of Science ®Google Scholar
• Hewawasam, E., G. Liu, D. W. Jeffery, B. S. Muhlhausler, and R. A. Gibson. 2017. A validated method for analyzing polyunsaturated free fatty acids from dried blood spots using LC-MS/MS. Prostaglandins, Leukotrienes, and Essential Fatty Acids 125:1–7. doi:10.1016/j.plefa.2017.08.010.
   PubMed Web of Science ®Google Scholar
• Hiki, M., T. Miyazaki, K. Shimada, Y. Sugita, M. Shimizu, T. Aikawa, S. Ouchi, T. Shiozawa, K. Takasu, S. Takahashi, et al. 2017. Significance of serum polyunsaturated fatty acid level imbalance in patients with acute venous thromboembolism. Journal of Atherosclerosis and Thrombosis 24 (10):1016–22. doi:10.5551/jat.37424.
   PubMed Web of Science ®Google Scholar
• Hishikari, K., S. Kimura, Y. Yamakami, K. Kojima, Y. Sagawa, H. Otani, T. Sugiyama, T. Kuwahara, H. Hikita, A. Takahashi, et al. 2015. The prognostic value of the serum eicosapentaenoic acid to arachidonic acid ratio in relation to clinical outcomes after endovascular therapy in patients with peripheral artery disease caused by femoropopliteal artery lesions. Atherosclerosis 239 (2):583–8. doi:10.1016/j.atherosclerosis.2015.02.035.
   PubMed Web of Science ®Google Scholar
• Hodson, L., C. M. Skeaff, and B. A. Fielding. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Progress in Lipid Research 47 (5):348–80. doi:10.1016/j.plipres.2008.03.003.
   PubMed Web of Science ®Google Scholar
• Husted, K. S., and E. V. Bouzinova. 2016. The importance of n-6/n-3 fatty acids ratio in the major depressive disorder. Medicina 52 (3):139–47. doi:10.1016/j.medici.2016.05.003.
   PubMedGoogle Scholar
• Ikeya, Y., N. Fukuyama, W. Kitajima, Y. Ogushi, and H. Mori. 2013. Comparison of eicosapentaenoic acid concentrations in plasma between patients with ischemic stroke and control subjects. Nutrition 29 (1):127–31. doi:10.1016/j.nut.2012.05.003.
   PubMed Web of Science ®Google Scholar
• Innes, J. K., and P. C. Calder. 2018. Omega-6 fatty acids and inflammation. Prostaglandins, Leukotrienes, and Essential Fatty Acids 132:41–8. doi:10.1016/j.plefa.2018.03.004.
   PubMed Web of Science ®Google Scholar
• Innis, S. M. 2008. Dietary omega 3 fatty acids and the developing brain. Brain Research 1237:35–43. doi:10.1016/j.brainres.2008.08.078.
   PubMed Web of Science ®Google Scholar
• Inoue, K., K. Kishida, A. Hirata, T. Funahashi, and I. Shimomura. 2013. Low serum eicosapentaenoic acid/arachidonic acid ratio in male subjects with visceral obesity. Nutrition & Metabolism 10:25. doi:10.1186/1743-7075-10-25.
   PubMed Web of Science ®Google Scholar
• Itakura, H., M. Yokoyama, M. Matsuzaki, Y. Saito, H. Origasa, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, T. Kita, et al. 2011. Relationships between plasma fatty acid composition and coronary artery disease. Journal of Atherosclerosis and Thrombosis 18 (2):99–107. doi:10.5551/jat.5876.
   PubMed Web of Science ®Google Scholar
• Jackson, K. H., and W. S. Harris. 2018. Blood fatty acid profiles: New biomarkers for cardiometabolic disease risk. Current Atherosclerosis Reports 20 (5):22. doi:10.1007/s11883-018-0722-1.
   PubMed Web of Science ®Google Scholar
• James, M. J., R. A. Gibson, and L. G. Cleland. 2000. Dietary polyunsaturated fatty acids and inflammatory mediator production. The American Journal of Clinical Nutrition 71 (1):343S–8S. doi:10.1093/ajcn/71.1.343s.
   PubMed Web of Science ®Google Scholar
• Johnston, D. T., P. A. Deuster, W. S. Harris, H. Macrae, and M. N. Dretsch. 2013. Red blood cell omega-3 fatty acid levels and neurocognitive performance in deployed U.S. Servicemembers. Nutritional Neuroscience 16 (1):30–8. doi:10.1179/1476830512Y.0000000025.
   PubMed Web of Science ®Google Scholar
• Johnson, G. H., and K. Fritsche. 2012. Effect of dietary linoleic acid on markers of inflammation in healthy persons: A systematic review of randomized controlled trials. Journal of the Academy of Nutrition and Dietetics 112 (7):1029–41. doi:10.1016/j.jand.2012.03.029.
   PubMed Web of Science ®Google Scholar
• Jump, D. B., D. Botolin, Y. Wang, J. Xu, B. Christian, and O. Demeure. 2005. Fatty acid regulation of hepatic gene transcription. The Journal of Nutrition 135 (11):2503–6. doi:10.1093/jn/135.11.2503.
   PubMed Web of Science ®Google Scholar
• Jurowski, K., K. Kochan, J. Walczak, M. Barańska, W. Piekoszewski, and B. Buszewski. 2017. Analytical techniques in lipidomics: State of the art. Critical Reviews in Analytical Chemistry 47 (5):418–37. doi:10.1080/10408347.2017.1310613.
   PubMed Web of Science ®Google Scholar
• Kangani, C. O., D. E. Kelley, and J. P. Delany. 2008. New method for GC/FID and GC-C-IRMS analysis of plasma free fatty acid concentration and isotopic enrichment. Journal of Chromatography B 873 (1):95–101. doi:10.1016/j.jchromb.2008.08.009.
   PubMed Web of Science ®Google Scholar
• Kihara, A. 2012. Very long-chain fatty acids: Elongation, physiology and related disorders. Journal of Biochemistry 152 (5):387–95. doi:10.1093/jb/mvs105.
   PubMed Web of Science ®Google Scholar
• Kohashi, K., A. Nakagomi, Y. Saiki, T. Morisawa, M. Kosugi, Y. Kusama, H. Atarashi, and W. Shimizu. 2014. Effects of eicosapentaenoic acid on the levels of inflammatory markers, cardiac function and long-term prognosis in chronic heart failure patients with dyslipidemia. Journal of Atherosclerosis and Thrombosis 21 (7):712–29. doi:10.5551/jat.21022.
   PubMed Web of Science ®Google Scholar
• Kondo, T., K. Ogawa, T. Satake, M. Kitazawa, K. Taki, S. Sugiyama, and T. Ozawa. 1986. Plasma-free eicosapentaenoic acid/arachidonic acid ratio: A possible new coronary risk factor. Clinical Cardiology 9 (9):413–6. doi:10.1002/clc.4960090905.
   PubMed Web of Science ®Google Scholar
• Kwak, S. M., S.-K. Myung, Y. J. Lee, H. G. Seo, and Korean Meta-analysis Study Group. 2012. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials. Archives of Internal Medicine 172:686–94. doi:10.1001/archinternmed.2012.262.
   PubMed Web of Science ®Google Scholar
• Langlois, K., and W. M. N. Ratnayake. 2015. Omega-3 index of Canadian adults. Health Reports 26 (11):3–11.
   PubMed Web of Science ®Google Scholar
• Leaf, D. A., W. E. Connor, L. Barstad, and G. Sexton. 1995. Incorporation of dietary n-3 fatty acids into the fatty acids of human adipose tissue and plasma lipid classes. The American Journal of Clinical Nutrition 62 (1):68–73. doi:10.1093/ajcn/62.1.68.
   PubMed Web of Science ®Google Scholar
• Lin, P.-Y., S.-Y. Huang, and K.-P. Su. 2010. A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression. Biological Psychiatry 68 (2):140–7. doi:10.1016/j.biopsych.2010.03.018.
   PubMed Web of Science ®Google Scholar
• Maki, K. C., F. Eren, M. E. Cassens, M. R. Dicklin, and M. H. Davidson. 2018. ω-6 polyunsaturated fatty acids and cardiometabolic health: Current evidence, controversies, and research gaps. Advances in Nutrition 9:688–700. doi:10.1093/advances/nmy038.
   PubMed Web of Science ®Google Scholar
• Manson, J. E., N. R. Cook, I. M. Lee, W. Christen, S. S. Bassuk, S. Mora, H. Gibson, C. M. Albert, D. Gordon, T. Copeland, et al. 2019. Marine n-3 fatty acids and prevention of cardiovascular disease and cancer. New England Journal of Medicine 380 (1):23–32. doi:10.1056/NEJMoa1811403.
   PubMed Web of Science ®Google Scholar
• Marangoni, F., C. Colombo, and C. Galli. 2004. A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: Applicability to nutritional and epidemiological studies. Analytical Biochemistry 326 (2):267–72. doi:10.1016/j.ab.2003.12.016.
   PubMed Web of Science ®Google Scholar
• Marangoni, F., C. Colombo, A. Martiello, E. Negri, and C. Galli. 2007. The fatty acid profiles in a drop of blood from a fingertip correlate with physiological, dietary and lifestyle parameters in volunteers. Prostaglandins, Leukotrienes, and Essential Fatty Acids 76 (2):87–92. doi:10.1016/j.plefa.2006.11.004.
   PubMed Web of Science ®Google Scholar
• Marklund, M., J. H. Y. Wu, F. Imamura, L. C. Del Gobbo, A. Fretts, J. de Goede, P. Shi, N. Tintle, M. Wennberg, S. Aslibekyan, et al. 2019. Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality. Circulation 139 (21):2422–36.
   PubMed Web of Science ®Google Scholar
• Martín-Venegas, R., R. Casillas, O. Jáuregui, and J. J. Moreno. 2011. Rapid simultaneous analysis of cyclooxygenase, lipoxygenase and cytochrome P-450 metabolites of arachidonic and linoleic acids using high performance liquid chromatography/mass spectrometry in tandem mode. Journal of Pharmaceutical and Biomedical Analysis 56 (5):976–82. doi:10.1016/j.jpba.2011.06.018.
   PubMed Web of Science ®Google Scholar
• Marventano, S., P. Kolacz, S. Castellano, F. Galvano, S. Buscemi, A. Mistretta, and G. Grosso. 2015. A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: Does the ratio really matter?. International Journal of Food Sciences and Nutrition 66 (6):611–22. doi:10.3109/09637486.2015.1077790.
   PubMed Web of Science ®Google Scholar
• Maskrey, B. H., I. L. Megson, A. G. Rossi, and P. D. Whitfield. 2013. Emerging importance of omega-3 fatty acids in the innate immune response: Molecular mechanisms and lipidomic strategies for their analysis. Molecular Nutrition & Food Research 57:1390–400. doi:10.1002/mnfr.201200723.
   PubMed Web of Science ®Google Scholar
• Micha, R., S. Khatibzadeh, P. Shi, S. Fahimi, S. Lim, K. G. Andrews, R. E. Engell, J. Powles, M. Ezzati, D. Mozaffarian, and Global Burden of Diseases Nutrition and Chronic Diseases Expert Group NutriCoDE. 2014. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: A systematic analysis including 266 country-specific nutrition surveys. BMJ 348:g2272. doi:10.1136/bmj.g2272.
   PubMed Web of Science ®Google Scholar
• Molendi-Coste, O., V. Legry, and I. A. Leclercq. 2011. Why and how meet n-3 PUFA dietary recommendations? Gastroenterology Research and Practice 2011:1–11. doi:10.1155/2011/364040.
   Web of Science ®Google Scholar
• Molfino, A., M. I. Amabile, S. Mazzucco, G. Biolo, A. Farcomeni, C. Ramaccini, S. Antonaroli, M. Monti, and M. Muscaritoli. 2017. Effect of oral docosahexaenoic acid (DHA) supplementation on DHA levels and omega-3 index in red blood cell membranes of breast cancer patients. Frontiers in Physiology 8:549. doi:10.3389/fphys.2017.00549.
   PubMed Web of Science ®Google Scholar
• Murphy, R. C., R. M. Barkley, K. Zemski Berry, J. Hankin, K. Harrison, C. Johnson, J. Krank, A. McAnoy, C. Uhlson, and S. Zarini. 2005. Electrospray ionization and tandem mass spectrometry of eicosanoids. Analytical Biochemistry 346 (1):1–42. doi:10.1016/j.ab.2005.04.042.
   PubMed Web of Science ®Google Scholar
• Musso, G., M. Cassader, E. Paschetta, and R. Gambino. 2018. Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis. Gastroenterology 155 (2):282–302. doi:10.1053/j.gastro.2018.06.031.
   PubMed Web of Science ®Google Scholar
• Nagata, M., J. Hata, Y. Hirakawa, N. Mukai, D. Yoshida, T. Ohara, H. Kishimoto, H. Kawano, T. Kitazono, Y. Kiyohara, et al. 2017. The ratio of serum eicosapentaenoic acid to arachidonic acid and risk of cancer death in a Japanese community: The Hisayama Study. Journal of Epidemiology 27 (12):578–83. doi:10.1016/j.je.2017.01.004.
   PubMed Web of Science ®Google Scholar
• Nelson, J. R., and S. Raskin. 2019. The eicosapentaenoic acid: Arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgraduate Medicine 131 (4):268–77. doi:10.1080/00325481.2019.1607414.
   PubMed Web of Science ®Google Scholar
• Nishizaki, Y., K. Shimada, and H. Daida. 2017. The balance of omega-3 polyunsaturated fatty acids for reducing residual risks in patients with coronary artery disease. Acta Cardiologica 72 (3):240–8. doi:10.1080/00015385.2017.1305174.
   PubMed Web of Science ®Google Scholar
• Nishizaki, Y., K. Shimada, S. Tani, T. Ogawa, J. Ando, M. Takahashi, M. Yamamoto, T. Shinozaki, K. Miyauchi, K. Nagao, et al. 2014. Significance of imbalance in the ratio of serum n-3 to n-6 polyunsaturated fatty acids in patients with acute coronary syndrome. The American Journal of Cardiology 113 (3):441–5. doi:10.1016/j.amjcard.2013.10.011.
   PubMed Web of Science ®Google Scholar
• Nishizawa, H., K. Hamazaki, T. Hamazaki, S. Fujioka, and S. Sawazaki. 2006. The relationship between tissue RBC n-3 fatty acids and pulse wave velocity. In Vivo (Athens, Greece) 20:307–10.
   PubMed Web of Science ®Google Scholar
• Nosaka, K., T. Miyoshi, M. Iwamoto, M. Kajiya, K. Okawa, S. Tsukuda, F. Yokohama, M. Sogo, T. Nishibe, N. Matsuo, et al. 2017. Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study. International Journal of Cardiology 228:173–9. doi:10.1016/j.ijcard.2016.11.105.
   PubMed Web of Science ®Google Scholar
• Okada, L. S. D. R. R., C. P. Oliveira, J. T. Stefano, M. A. Nogueira, I. D. C. G. D. Silva, F. B. Cordeiro, V. A. F. Alves, R. S. Torrinhas, F. J. Carrilho, P. Puri, et al. 2018. Omega-3 PUFA modulate lipogenesis, ER stress, and mitochondrial dysfunction markers in NASH - Proteomic and lipidomic insight. Clinical Nutrition 37 (5):1474–84. doi:10.1016/j.clnu.2017.08.031.
   PubMed Web of Science ®Google Scholar
• Okamoto, K., A. Sato, K. Matsukawa, T. Kasuga, and Y. Uchigata. 2015. Impact of eicosapentaenoic acid/arachidonic acid ratio on left ventricular structure in patients with diabetes. Diabetology International 6 (1):46–54. doi:10.1007/s13340-014-0172-0.
   Web of Science ®Google Scholar
• Ostermann, A. I., I. Willenberg, and N. H. Schebb. 2015. Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS. Analytical and Bioanalytical Chemistry 407 (5):1403–14. doi:10.1007/s00216-014-8377-4.
   PubMed Web of Science ®Google Scholar
• Parker, H. M., N. A. Johnson, C. A. Burdon, J. S. Cohn, H. T. O’Connor, and J. George. 2012. Omega-3 supplementation and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Journal of Hepatology 56 (4):944–51. doi:10.1016/j.jhep.2011.08.018.
   PubMed Web of Science ®Google Scholar
• Parker, H. M., H. T. O’Connor, S. E. Keating, J. S. Cohn, M. L. Garg, I. D. Caterson, J. George, and N. A. Johnson. 2015. Efficacy of the omega-3 index in predicting non-alcoholic fatty liver disease in overweight and obese adults: A pilot study. British Journal of Nutrition 114 (5):780–7. doi:10.1017/S0007114515002305.
   PubMed Web of Science ®Google Scholar
• Patterson, A. C., A. Chalil, J. J. Aristizabal Henao, I. T. Streit, and K. D. Stark. 2015. Omega-3 polyunsaturated fatty acid blood biomarkers increase linearly in men and women after tightly controlled intakes of 0.25, 0.5, and 1 g/d of EPA + DHA. Nutrition Research 35 (12):1040–51. doi:10.1016/j.nutres.2015.09.016.
   PubMed Web of Science ®Google Scholar
• Patterson, E., R. Wall, G. F. Fitzgerald, R. P. Ross, and C. Stanton. 2012. Health implications of high dietary omega-6 polyunsaturated fatty acids. Journal of Nutrition and Metabolism 2012:1–16. doi:10.1155/2012/539426.
   Google Scholar
• Pettinelli, P., T. Del Pozo, J. Araya, R. Rodrigo, A. V. Araya, G. Smok, A. Csendes, L. Gutierrez, J. Rojas, O. Korn, et al. 2009. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. Biochimica et Biophysica Acta (Bba) - Molecular Basis of Disease 1792 (11):1080–6. doi:10.1016/j.bbadis.2009.08.015.
   PubMed Web of Science ®Google Scholar
• Poppitt, S. D., P. Kilmartin, P. Butler, and G. F. Keogh. 2005. Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial. Lipids in Health and Disease 4 (1):30.
   PubMedGoogle Scholar
• Pottala, J. V., J. A. Talley, S. W. Churchill, D. A. Lynch, C. von Schacky, and W. S. Harris. 2012. Red blood cell fatty acids are associated with depression in a case-control study of adolescents. Prostaglandins, Leukotrienes, and Essential Fatty Acids 86 (4-5):161–5. doi:10.1016/j.plefa.2012.03.002.
   PubMed Web of Science ®Google Scholar
• Pottala, J. V., K. Yaffe, J. G. Robinson, M. A. Espeland, R. Wallace, and W. S. Harris. 2014. Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI study. Neurology 82 (5):435–42. doi:10.1212/WNL.0000000000000080.
   PubMed Web of Science ®Google Scholar
• Preston Mason, R. 2019. New insights into mechanisms of action for omega-3 fatty acids in atherothrombotic cardiovascular disease. Current Atherosclerosis Reports 21 (1):2–11. doi:10.1007/s11883-019-0762-1.
   PubMed Web of Science ®Google Scholar
• Puri, P., R. A. Baillie, M. M. Wiest, F. Mirshahi, J. Choudhury, O. Cheung, C. Sargeant, M. J. Contos, and A. J. Sanyal. 2007. A lipidomic analysis of nonalcoholic fatty liver disease. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 46 (4):1081–90. doi:10.1002/hep.21763.
   PubMed Web of Science ®Google Scholar
• Puri, P., M. M. Wiest, O. Cheung, F. Mirshahi, C. Sargeant, H. K. Min, M. J. Contos, R. K. Sterling, M. Fuchs, H. Zhou, et al. 2009. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50 (6):1827–38. doi:10.1002/hep.23229.
   PubMed Web of Science ®Google Scholar
• Rizos, E. C., E. E. Ntzani, E. Bika, M. S. Kostapanos, and M. S. Elisaf. 2012. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: A systematic review and meta-analysis. JAMA 308 (10):1024–33. doi:10.1001/2012.jama.11374.
   PubMed Web of Science ®Google Scholar
• Rizzo, A. M., P. A. Corsetto, G. Montorfano, A. Opizzi, M. Faliva, A. Giacosa, G. Ricevuti, C. Pelucchi, B. Berra, and M. Rondanelli. 2012. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: Omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters. Nutrition Journal 11 (1):82. doi:10.1186/1475-2891-11-82.
   PubMedGoogle Scholar
• Rizzo, A. M., G. Montorfano, M. Negroni, L. Adorni, P. Berselli, P. Corsetto, K. Wahle, and B. Berra. 2010. A rapid method for determining arachidonic: Eicosapentaenoic acid ratios in whole blood lipids: Correlation with erythrocyte membrane ratios and validation in a large Italian population of various ages and pathologies. Lipids in Health and Disease 9 (1):7. doi:10.1186/1476-511X-9-7.
   PubMedGoogle Scholar
• Rose, M., M. Veysey, M. Lucock, S. Niblett, K. King, S. Baines, and M. L. Garg. 2016. Association between erythrocyte omega-3 polyunsaturated fatty acid levels and fatty liver index in older people is sex dependent. Journal of Nutrition & Intermediary Metabolism 5:78–85. doi:10.1016/j.jnim.2016.04.007.
   Google Scholar
• Russo, G. L. 2009. Dietary n-6 and n-3 polyunsaturated fatty acids: From biochemistry to clinical implications in cardiovascular prevention. Biochemical Pharmacology 77 (6):937–46. doi:10.1016/j.bcp.2008.10.020.
   PubMed Web of Science ®Google Scholar
• SanGiovanni, J. P., and E. Y. Chew. 2005. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research 24 (1):87–138. doi:10.1016/j.preteyeres.2004.06.002.
   PubMed Web of Science ®Google Scholar
• Sarter, B., K. S. Kelsey, T. A. Schwartz, and W. S. Harris. 2015. Blood docosahexaenoic acid and eicosapentaenoic acid in vegans: Associations with age and gender and effects of an algal-derived omega-3 fatty acid supplement. Clinical Nutrition 34 (2):212–8. doi:10.1016/j.clnu.2014.03.003.
   PubMed Web of Science ®Google Scholar
• Schmitz, G., and J. Ecker. 2008. The opposing effects of n-3 and n-6 fatty acids. Progress in Lipid Research 47 (2):147–55. doi:10.1016/j.plipres.2007.12.004.
   PubMed Web of Science ®Google Scholar
• Schwanke, R. C., R. Marcon, A. F. Bento, and J. B. Calixto. 2016. EPA- and DHA-derived resolvins’ actions in inflammatory bowel disease. European Journal of Pharmacology 785:156–64. doi:10.1016/j.ejphar.2015.08.050.
   PubMed Web of Science ®Google Scholar
• Scola, G., A. Versace, A. H. Metherel, L. A. Monsalve-Castro, M. L. Phillips, R. P. Bazinet, and A. C. Andreazza. 2018. Alterations in peripheral fatty acid composition in bipolar and unipolar depression. Journal of Affective Disorders 233:86–91. doi:10.1016/j.jad.2017.12.025.
   PubMed Web of Science ®Google Scholar
• Serikawa, T., S. Miura, M. Okabe, H. Hongo, M. Tokutome, T. Yoshikawa, K. Takesue, S. Adachi, K. Osaka, R. Matsukawa, et al. 2014. Ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients. Journal of Cardiology 63 (1):35–40. doi:10.1016/j.jjcc.2013.06.016.
   PubMed Web of Science ®Google Scholar
• Serra-Majem, L., M. Nissensohn, N. C. Øverby, and K. Fekete. 2012. Dietary methods and biomarkers of omega 3 fatty acids: A systematic review. British Journal of Nutrition 107 (S2):S64–S76. doi:10.1017/S000711451200147X.
   PubMedGoogle Scholar
• Shahidi, F., and P. Ambigaipalan. 2018. Omega-3 polyunsaturated fatty acids and their health benefits. Annual Review of Food Science and Technology 9 (1):345–81. doi:10.1146/annurev-food-111317-095850.
   PubMedGoogle Scholar
• Shearer, G. C., J. Chen, Y. Chen, and W. S. Harris. 2009. Myocardial infarction does not affect fatty-acid profiles in rats. Prostaglandins, Leukotrienes, and Essential Fatty Acids 81 (5-6):411–6. doi:10.1016/j.plefa.2009.08.002.
   PubMed Web of Science ®Google Scholar
• Shibata, M., T. Ohara, D. Yoshida, J. Hata, N. Mukai, H. Kawano, S. Kanba, T. Kitazono, and T. Ninomiya. 2018. Association between the ratio of serum arachidonic acid to eicosapentaenoic acid and the presence of depressive symptoms in a general Japanese population: The Hisayama Study. Journal of Affective Disorders 237:73–9. doi:10.1016/j.jad.2018.05.004.
   PubMed Web of Science ®Google Scholar
• Simopoulos, A. P. 2002. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomedicine & Pharmacotherapy 56:365–79. doi:10.1016/S0753-3322(02)00253-6.
   PubMed Web of Science ®Google Scholar
• Simopoulos, A. P. 2006. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 60 (9):502–7. doi:10.1016/j.biopha.2006.07.080.
   PubMed Web of Science ®Google Scholar
• Skeaff, C. M., and J. Miller. 2009. Dietary fat and coronary heart disease: Summary of evidence from prospective cohort and randomised controlled trials. Annals of Nutrition and Metabolism 55:173–201. doi:10.1159/000229002.
   PubMed Web of Science ®Google Scholar
• Song, C., C.-H. Shieh, Y.-S. Wu, A. Kalueff, S. Gaikwad, and K.-P. Su. 2016. The role of omega-3 polyunsaturated fatty acids eicosapentaenoic and docosahexaenoic acids in the treatment of major depression and Alzheimer’s disease: Acting separately or synergistically?. Progress in Lipid Research 62:41–54. doi:10.1016/j.plipres.2015.12.003.
   PubMed Web of Science ®Google Scholar
• Spahis, S., F. Alvarez, N. Ahmed, J. Dubois, R. Jalbout, M. Paganelli, K. Grzywacz, E. Delvin, N. Peretti, and E. Levy. 2018. Non-alcoholic fatty liver disease severity and metabolic complications in obese children: Impact of omega-3 fatty acids. The Journal of Nutritional Biochemistry 58:28–36. doi:10.1016/j.jnutbio.2018.03.025.
   PubMed Web of Science ®Google Scholar
• Sugiyama, E., Y. Ishikawa, Y. Li, T. Kagai, M. Nobayashi, N. Tanaka, Y. Kamijo, S. Yokoyama, A. Hara, and T. Aoyama. 2008. Eicosapentaenoic acid lowers plasma and liver cholesterol levels in the presence of peroxisome proliferators-activated receptor alpha. Life Sciences 83 (1-2):19–28. doi:10.1016/j.lfs.2008.04.011.
   PubMed Web of Science ®Google Scholar
• Suzuki, A., H. Ando, H. Takashima, S. Kumagai, A. Kurita, K. Waseda, Y. Suzuki, T. Mizuno, K. Harada, T. Uetani, et al. 2014. Effects of polyunsaturated fatty acids on periprocedural myocardial infarction after elective percutaneous coronary intervention. Eurointervention 10 (7):792–8. doi:10.4244/EIJV10I7A138.
   PubMed Web of Science ®Google Scholar
• Svegliati-Baroni, G., I. Pierantonelli, P. Torquato, R. Marinelli, C. Ferreri, C. Chatgilialoglu, D. Bartolini, and F. Galli. 2019. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease. Free Radical Biology and Medicine 144:293–309. doi:10.1016/j.freeradbiomed.2019.05.029.
   PubMed Web of Science ®Google Scholar
• Tanaka, K., Y. Ishikawa, M. Yokoyama, H. Origasa, M. Matsuzaki, Y. Saito, Y. Matsuzawa, J. Sasaki, S. Oikawa, H. Hishida, et al. 2008. Reduction in the recurrence of stroke by eicosapentaenoic acid for hypercholesterolemic patients: Subanalysis of the JELIS trial. Stroke 39 (7):2052–8. doi:10.1161/STROKEAHA.107.509455.
   PubMed Web of Science ®Google Scholar
• Torquato, P., D. Giusepponi, A. Alisi, R. Galarini, D. Bartolini, M. Piroddi, L. Goracci, A. Di Veroli, G. Cruciani, A. Crudele, et al. 2019. Nutritional and lipidomics biomarkers of docosahexaenoic acid-based multivitamin therapy in pediatric NASH. Scientific Reports 9 (1):2045. doi:10.1038/s41598-018-37209-y.
   PubMedGoogle Scholar
• Tortosa-Caparrós, E., D. Navas-Carrillo, F. Marín, and E. Orenes-Piñero. 2017. Anti-inflammatory effects of omega 3 and omega 6 polyunsaturated fatty acids in cardiovascular disease and metabolic syndrome. Critical Reviews in Food Science and Nutrition 57 (16):3421–9. doi:10.1080/10408398.2015.1126549.
   PubMed Web of Science ®Google Scholar
• Tutino, V., V. De Nunzio, M. G. Caruso, C. Bonfiglio, I. Franco, A. Mirizzi, G. De Leonardis, R. Cozzolongo, V. Giannuzzi, G. Giannelli, et al. 2018. Aerobic physical activity and a low glycemic diet reduce the AA/EPA ratio in red blood cell membranes of patients with NAFLD. Nutrients 10 (9):1299. doi:10.3390/nu10091299.
   Web of Science ®Google Scholar
• Tutino, V., V. De Nunzio, M. G. Caruso, N. Veronese, D. Lorusso, M. Di Masi, M. L. Benedetto, and M. Notarnicola. 2019. Elevated AA/EPA ratio represents an inflammatory biomarker in tumor tissue of metastatic colorectal cancer patients. International Journal of Molecular Sciences 20 (8):2050. doi:10.3390/ijms20082050.
   Web of Science ®Google Scholar
• van der Wurff, I. S. M., C. von Schacky, K. Berge, M. P. Zeegers, P. A. Kirschner, and R. H. M. de Groot. 2016. Association between blood omega-3 index and cognition in typically developing Dutch adolescents. Nutrients 8 (1):13. doi:10.3390/nu8010013.
   PubMed Web of Science ®Google Scholar
• von Schacky, C. 2014. Omega-3 index and cardiovascular health. Nutrients 6 (2):799–814. doi:10.3390/nu6020799.
   PubMed Web of Science ®Google Scholar
• von Schacky, C. 2015. Omega-3 fatty acids in cardiovascular disease–An uphill battle. Prostaglandins, Leukotrienes, and Essential Fatty Acids 92:41–7. doi:10.1016/j.plefa.2014.05.004.
   PubMed Web of Science ®Google Scholar
• von Schacky, C., S. Fischer, and P. C. Weber. 1985. Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans. Journal of Clinical Investigation 76 (4):1626–31.
   PubMed Web of Science ®Google Scholar
• Wada, M., C. J. DeLong, Y. H. Hong, C. J. Rieke, I. Song, R. S. Sidhu, C. Yuan, M. Warnock, A. H. Schmaier, C. Yokoyama, et al. 2007. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. Journal of Biological Chemistry 282 (31):22254–66. doi:10.1074/jbc.M703169200.
   PubMed Web of Science ®Google Scholar
• Walker, R. E., K. H. Jackson, N. L. Tintle, G. C. Shearer, A. Bernasconi, S. Masson, R. Latini, B. Heydari, R. Y. Kwong, M. Flock, et al. 2019. Predicting the effects of supplemental EPA and DHA on the omega-3 index. The American Journal of Clinical Nutrition 110 (4):1034–40. doi:10.1093/ajcn/nqz161.
   PubMed Web of Science ®Google Scholar
• Walle, P., M. Takkunen, V. Männistö, M. Vaittinen, M. Lankinen, V. Kärjä, P. Käkelä, J. Ågren, M. Tiainen, U. Schwab, et al. 2016. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity. Metabolism 65 (5):655–66. doi:10.1016/j.metabol.2016.01.011.
   PubMed Web of Science ®Google Scholar
• Watanabe, S., A. Yoshihisa, Y. Kanno, M. Takiguchi, T. Yokokawa, A. Sato, S. Miura, T. Shimizu, S. Abe, T. Sato, et al. 2016. Associations with eicosapentaenoic acid to arachidonic acid ratio and mortality in hospitalized heart failure patients. Journal of Cardiac Failure 22 (12):962–9. doi:10.1016/j.cardfail.2016.04.017.
   PubMed Web of Science ®Google Scholar
• Whelan, J. 1996. Antagonistic effects of dietary arachidonic acid and n-3 polyunsaturated fatty acids. The Journal of Nutrition 126 (suppl_4):1086S–91S. doi:10.1093/jn/126.suppl_4.1086S.
   PubMed Web of Science ®Google Scholar
• Willett, W. C. 2007. The role of dietary n-6 fatty acids in the prevention of cardiovascular disease. Journal of Cardiovascular Medicine 8 (Suppl 1):S42–S45. doi:10.2459/01.JCM.0000289275.72556.13.
   PubMed Web of Science ®Google Scholar
• Williams, C. D., B. M. Whitley, C. Hoyo, D. J. Grant, J. D. Iraggi, K. A. Newman, L. Gerber, L. A. Taylor, M. G. McKeever, and S. J. Freedland. 2011. A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer. Nutrition Research 31 (1):1–8. doi:10.1016/j.nutres.2011.01.002.
   PubMed Web of Science ®Google Scholar
• Williams, C. M., and G. Burdge. 2006. Long-chain n-3 PUFA: Plant v. marine sources. Proceedings of the Nutrition Society 65 (1):42–50. doi:10.1079/PNS2005473.
   PubMed Web of Science ®Google Scholar
• Wood, K. E., E. Mantzioris, R. A. Gibson, C. E. Ramsden, and B. S. Muhlhausler. 2015. The effect of modifying dietary LA and ALA intakes on omega-3 long chain polyunsaturated fatty acid (n-3 LCPUFA) status in human adults: A systematic review and commentary. Prostaglandins, Leukotrienes, and Essential Fatty Acids 95:47–55. doi:10.1016/j.plefa.2015.01.001.
   PubMed Web of Science ®Google Scholar
• Yang, K., and X. Han. 2016. Lipidomics: Techniques, applications, and outcomes related to biomedical sciences. Trends in Biochemical Sciences 41 (11):954–69. doi:10.1016/j.tibs.2016.08.010.
   PubMed Web of Science ®Google Scholar
• Yokoyama, M., H. Origasa, M. Matsuzaki, Y. Matsuzawa, Y. Saito, Y. Ishikawa, S. Oikawa, J. Sasaki, H. Hishida, H. Itakura, et al. 2007. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. The Lancet 369 (9567):1090–8. doi:10.1016/S0140-6736(07)60527-3.
   PubMed Web of Science ®Google Scholar
• Zárate, R., N. El Jaber-Vazdekis, N. Tejera, J. A. Pérez, and C. Rodríguez. 2017. Significance of long chain polyunsaturated fatty acids in human health. Clinical and Translational Medicine 6 (1):25. doi:10.1186/s40169-017-0153-6.
   PubMed Web of Science ®Google Scholar
• Zelber-Sagi, S., D. Nitzan-Kaluski, R. Goldsmith, M. Webb, L. Blendis, Z. Halpern, and R. Oren. 2007. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. Journal of Hepatology 47 (5):711–7. doi:10.1016/j.jhep.2007.06.020.
   PubMed Web of Science ®Google Scholar
• Zhang, L. J., B. Chen, J. J. Zhang, J. Li, Q. Yang, Q. S. Zhong, S. Zhan, H. Liu, and C. Cai. 2017. Serum polyunsaturated fatty acid metabolites as useful tool for screening potential biomarker of colorectal cancer. Prostaglandins, Leukotrienes, and Essential Fatty Acids 120:25–31. doi:10.1016/j.plefa.2017.04.003.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., J. Chen, J. Qiu, Y. Li, J. Wang, and J. Jiao. 2015. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies. The American Journal of Clinical Nutrition 103 (2):330–40. doi:10.3945/ajcn.115.124081.
   PubMed Web of Science ®Google Scholar
• Zhao, Y. Y., H. Miao, X. L. Cheng, and F. Wei. 2015. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease. Chemico Biological Interactions 240:220–38. doi:10.1016/j.cbi.2015.09.005.
   PubMed Web of Science ®Google Scholar